Life Science Strategy Group Presents CRO Benchmark Study at DIA Conference

The Present and Future of Pharmaceutical Development Outsourcing: Where Are We Today and Where Are We Going?

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This

Menlo Park, CA (PRWEB) June 10, 2014

Life Science Strategy Group (LSSG), a leading strategic consulting firm to the CRO industry, announces Jon Meyer, MS, MBA, as a presenter at DIA’s 50th Annual Meeting. The event takes place June 15-19, 2014 at the San Diego Convention Center in San Diego, California.

Mr. Meyer speaks on the topic of "The Present and Future of Pharmaceutical Development Outsourcing: Where Are We Today and Where Are We Going?" at 10:30 AM on June 18, 2014. The presentation, findings from a benchmark survey of over 100 OutsourcePharma Advisory Board members (http://www.outsourcepharma.com), focuses on present and future use of outsourced development services providers including sponsor utilization of, satisfaction with, and rationale for use of strategic partnerships, preferred partners, and functional outsourcing.

“This forum will present novel, proprietary data collected from a quantitative global sample of outsourcing professionals at biopharmaceutical companies to understand the frequency of use of various outsourcing strategies and also explore how outsourcing methods are expected to evolve over the next five years,” said Jon Meyer, Co-founder and CRO Practice Leader of Life Science Strategy Group, LLC.

DIA’s Annual Meeting is the nation’s largest multidisciplinary event bringing together a community of life science professionals at all levels and across all disciplines involved in the discovery, development, and life cycle management of medical products. These professionals share a common goal to foster innovation that will lead to the development of safe and effective medical products and therapies to patients.

About Life Science Strategy Group, LLC
Life Science Strategy Group, LLC specializes in strategic consulting, market research engagements and syndicated publications across a variety of therapeutic, technology and service industries including contract research services, pharmaceutical, biotechnology, medical devices, diagnostics and drug discovery.
###


Contact